The Bitfury Group, a U.S.-based blockchain company, joined forces with Insilico Medicine, a provider of artificial intelligence and bioinformatics, to develop healthcare applications using blockchain technology.
The companies signed a memorandum of understanding, under which they plan to collaborate in academic and commercial settings. They will focus on studying and developing blockchain and AI solutions for sharing, managing, tracking and validating healthcare data.
"By partnering with Insilico, we will be able to combine their expertise in deep learning and bioinformatics with our blockchain proficiency and real-time solutions to create bespoke and innovative new products for the healthcare sector," said Valery Vavilov, founder and CEO of The Bitfury Group.